By Lauren Rashap, CN
Hi friends, your clinical nutritionist here, to spell it out or dispel some of the myths surrounding miracle weight loss drugs that we’ve all been talking about and even taking, perhaps indiscriminately and incorrectly!
Semaglutides aka GLP-1 Inhibitors like Wevovy, Ozempic, Monjaro have found their way to 1 in 8 Americans across the United States. While initially this statistic surprised me, I had to reflect on the staggering number of people in our country with pre diabetes and type 2 diabetes which is 1 in 3 Americans if current trends continue. (more…)